Compounds > clopidogrel

clopidogrel and Libman-Sacks Disease

clopidogrel has been researched along with Libman-Sacks Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Blanco, P; Bonnet, F; Duffau, P; Gensous, N; Lazaro, E; Pellegrin, I; Richez, C; Savel, H; Thiebaut, R; Truchetet, ME; Vial, G1
Batteux, F; Blanco, P; Bordes, C; Douchet, I; Duffau, P; Goulvestre, C; Lazaro, E; Moreau, JF; Nicco, C; Pellegrin, JL; Richez, C; Seneschal, J; Viallard, JF; Weil, B1
Matthai, WH; Patel, PJ; Untereker, WJ1
Bengtsson, AA; Erling, P; Erlinge, D; Sturfelt, G; Truedsson, L; Wang, L1
Hollman, JL; Olivier, AC1

Trials

1 trial(s) available for clopidogrel and Libman-Sacks Disease

ArticleYear
The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study.
    Joint bone spine, 2021, Volume: 88, Issue:2

    Topics: CD40 Ligand; Clopidogrel; Genetic Predisposition to Disease; Humans; Lupus Erythematosus, Systemic; Pilot Projects

2021

Other Studies

4 other study(ies) available for clopidogrel and Libman-Sacks Disease

ArticleYear
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Science translational medicine, 2010, Sep-01, Volume: 2, Issue:47

    Topics: Animals; Autoantibodies; Blood Platelets; CD40 Ligand; Clopidogrel; Dendritic Cells; Disease Models, Animal; Humans; Interferon-alpha; Lupus Erythematosus, Systemic; Mice; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, IgG; Ticlopidine

2010
Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy.
    Cardiology, 2011, Volume: 118, Issue:1

    Topics: Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Humans; Lupus Erythematosus, Systemic; Peptides; Platelet Aggregation Inhibitors; Ticlopidine

2011
Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus.
    Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:8

    Topics: Adolescent; Adult; Blood Platelets; Blotting, Western; Clopidogrel; Clusterin; Dimerization; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Female; Glycoproteins; Humans; Linear Models; Lupus Erythematosus, Systemic; Male; Membrane Proteins; Middle Aged; Molecular Chaperones; Platelet Activation; Platelet Aggregation; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Ticlopidine

2004
Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
    The Journal of invasive cardiology, 2006, Volume: 18, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation Disorders; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors

2006